https://www.selleckchem.com/products/PD-98059.html
ed by combined model revealed that high-risk patients have a poor prognosis compared with low-risk patients (Log-rank P less then 0.0001). Conclusion We demonstrated that the radiomics model reflected by CXCL8 combined with tumor stage information is a reliable approach to predict the prognosis in CRC patients and has a potential ability in assisting clinical decision-making.Monocarboxylate transporter 1 (MCT1) participates in the transport of lactate to facilitate metabolic reprogramming during tumor progression. Tumor-associated macr
Like
Comment
Share
